Recent Quotes (30 days)

You have no recent quotes
chg | %

Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

ALKS 50.42 -0.16 (-0.32%)
price chart
Alkermes Stands To Gain From Revenue Increase, Upcoming NDA Submission
Alkermes Plc (NASDAQ:ALKS) engages in developing products and technology platforms for treating various diseases. The company has a two-drug portfolio and its product pipeline is in mature stage.
Is It Too Late To Buy Alkermes plc (ALKS)?
Alkermes plc (NASDAQ:ALKS), a biotechnology company based in Ireland, received a lot of attention from a substantial price movement on the NasdaqGS in the over the last few months, increasing to $59.66 at one point, and dropping to the lows of $49.16.
Alkermes PLC (ALKS) Director Sells $75960.00 in Stock  The Ledger Gazette
Q2 2017 Sentiment Alkermes PLC (NASDAQ:ALKS)  WeeklyHub
Bearish Signals Shown in Alkermes Plc (ALKS) Charts
Alkermes Plc (ALKS) touched 50.58 on a recent bid indicating that the Tenkan line is still hovering below the Kijun Sen. This represents bearish momentum for the shares.
Alkermes to Present New Clinical Data on ALKS 8700 at MSParis2017, the 7
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that two posters on ALKS 8700, a novel, oral monomethyl fumarate (MMF) prodrug candidate in development for the treatment of relapsing forms of multiple sclerosis (MS), will be ...
Alkermes PLC (ALKS) Given a $81.00 Price Target at Mizuho
Mizuho set a $81.00 price target on Alkermes PLC (NASDAQ:ALKS) in a research report sent to investors on Saturday. The firm currently has a buy rating on the stock.
JPMorgan Chase & Co. Has $2.76 Million Position in Alkermes PLC (ALKS)  The Ledger Gazette
Alkermes PLC (ALKS) Given a $81.00 Price Target by Mizuho Analysts  StockNewsTimes
Alkermes Plc (ALKS) Analysts See $-0.15 EPS
Investors sentiment increased to 1.12 in 2017 Q2. Its up 0.01, from 1.11 in 2017Q1. It increased, as 33 investors sold Alkermes Plc shares while 72 reduced holdings. 41 funds opened positions while 77 raised stakes. 143.16 million shares or 1.87% more ...
Rock Springs Capital Management LP Has Trimmed Position in Alkermes Plc (ALKS ...
Rock Springs Capital Management Lp decreased its stake in Alkermes Plc (ALKS) by 58.4% based on its latest 2017Q2 regulatory filing with the SEC.
Alkermes plc (ALKS) is at $50.56 per share and Masimo Corporation (MASI) is ...
In latest trading activity; Alkermes plc (ALKS) snatched the consideration from Investors, when its current damaging picture was seen that is promoting bad performance.
Technicals in Focus: Alkermes plc (NASDAQ: ALKS)
On Monday, Shares of Alkermes plc (NASDAQ: ALKS) expressed a change of -0.44% and is currently trading at $50.07. The stock exchanged hands with 205,493 numbers of shares compared to its average daily volume of 704.14K shares.
Alkermes to Host Conference Call to Discuss Third Quarter 2017 Financial Results
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call and webcast presentation at 8:30 a.m. ET (1:30 p.m.